ITBO910024A1 - Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. - Google Patents
Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale.Info
- Publication number
- ITBO910024A1 ITBO910024A1 IT000024A ITBO910024A ITBO910024A1 IT BO910024 A1 ITBO910024 A1 IT BO910024A1 IT 000024 A IT000024 A IT 000024A IT BO910024 A ITBO910024 A IT BO910024A IT BO910024 A1 ITBO910024 A1 IT BO910024A1
- Authority
- IT
- Italy
- Prior art keywords
- glycosaminoglicans
- pharmaceutical formulations
- formulations containing
- absorbable
- orally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO910024A IT1245761B (it) | 1991-01-30 | 1991-01-30 | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
US07/821,455 US5252339A (en) | 1991-01-30 | 1992-01-15 | Pharmaceutical compositions containing orally absorbable glycosamimoglycans |
EP92100732A EP0497162B1 (en) | 1991-01-30 | 1992-01-17 | Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
DE69212608T DE69212608T2 (de) | 1991-01-30 | 1992-01-17 | Arzneimittel enthaltend oral absorbierbare Glycosaminoglycane |
ES92100732T ES2090368T3 (es) | 1991-01-30 | 1992-01-17 | Composiciones farmaceuticas que contienen glucosaminoglicanos absorbibles por via oral. |
CA002059865A CA2059865C (en) | 1991-01-30 | 1992-01-22 | Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
JP4013943A JPH0755907B2 (ja) | 1991-01-30 | 1992-01-29 | 経口吸収可能なグリコサミノグリカンを含有する製剤 |
KR1019920001330A KR100210359B1 (ko) | 1991-01-30 | 1992-01-30 | 경구용 글리코스아미노글리칸을 함유하는 의약 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITBO910024A IT1245761B (it) | 1991-01-30 | 1991-01-30 | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
Publications (3)
Publication Number | Publication Date |
---|---|
ITBO910024A0 ITBO910024A0 (it) | 1991-01-30 |
ITBO910024A1 true ITBO910024A1 (it) | 1992-07-30 |
IT1245761B IT1245761B (it) | 1994-10-14 |
Family
ID=11337212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITBO910024A IT1245761B (it) | 1991-01-30 | 1991-01-30 | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5252339A (it) |
EP (1) | EP0497162B1 (it) |
JP (1) | JPH0755907B2 (it) |
KR (1) | KR100210359B1 (it) |
CA (1) | CA2059865C (it) |
DE (1) | DE69212608T2 (it) |
ES (1) | ES2090368T3 (it) |
IT (1) | IT1245761B (it) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1256236B (it) * | 1992-12-23 | 1995-11-29 | Mediolanum Farmaceutici Srl | Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani |
IT1270846B (it) * | 1993-05-10 | 1997-05-13 | Alfa Wassermann Spa | Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica. |
US5801162A (en) * | 1993-09-30 | 1998-09-01 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Dermatan sulfate compositions and antithrombotic compositions containing same |
US5888984A (en) * | 1994-05-12 | 1999-03-30 | Dermal Research Laboratories, Inc. | Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
DE19501266A1 (de) * | 1995-01-18 | 1996-07-25 | Madaus Ag | Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln |
US6262255B1 (en) | 1995-04-05 | 2001-07-17 | Biomm, Inc. | Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them |
GB2305604B (en) * | 1995-09-29 | 1999-06-23 | Quest Vitamins Ltd | Carrier base material |
US6217863B1 (en) | 1995-10-30 | 2001-04-17 | Massachusetts Institute Of Technology | Rationally designed polysaccharide lyases derived from heparinase I |
IT1285546B1 (it) * | 1996-01-16 | 1998-06-18 | Alfa Wassermann Spa | Uso del dermatano solfato a basso peso molecolare e delle specialita' medicinali che lo contengono nella terapia e nella prevenzione della |
US6607751B1 (en) * | 1997-10-10 | 2003-08-19 | Intellipharamaceutics Corp. | Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum |
US6476005B1 (en) | 1998-03-24 | 2002-11-05 | George D. Petito | Oral and injectable nutritional composition |
US7691829B2 (en) * | 1998-03-24 | 2010-04-06 | Petito George D | Composition and method for healing tissues |
US20050208114A1 (en) * | 1998-03-24 | 2005-09-22 | Petito George D | Composition and method for healing tissues |
US6645948B2 (en) | 1998-03-24 | 2003-11-11 | George D. Petito | Nutritional composition for the treatment of connective tissue |
WO2000012726A2 (en) * | 1998-08-27 | 2000-03-09 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase i and ii |
US7056504B1 (en) | 1998-08-27 | 2006-06-06 | Massachusetts Institute Of Technology | Rationally designed heparinases derived from heparinase I and II |
IL127826A0 (en) * | 1998-12-29 | 1999-10-28 | Laster Gail | Restenosis drug therapy |
IL127896A0 (en) * | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
WO2000044367A2 (en) | 1999-02-01 | 2000-08-03 | Dermal Research Laboratories, Inc. | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
US8119159B2 (en) | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
ES2301477T3 (es) * | 1999-02-22 | 2008-07-01 | Merrion Research I Limited | Forma de dosificacion oral solida que contiene un potenciador. |
US7412332B1 (en) * | 1999-04-23 | 2008-08-12 | Massachusetts Institute Of Technology | Method for analyzing polysaccharides |
WO2001002443A1 (en) * | 1999-06-30 | 2001-01-11 | Hamilton Civic Hospitals Research Development, Inc | Heparin compositions that inhibit clot associated coagulation factors |
US6458383B2 (en) * | 1999-08-17 | 2002-10-01 | Lipocine, Inc. | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
AU2001243512C1 (en) * | 2000-03-08 | 2008-04-17 | Massachusetts Institute Of Technology | Heparinase III and uses thereof |
US7259152B2 (en) * | 2000-06-07 | 2007-08-21 | Alfa Wasserman, Inc. | Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
IL154771A0 (en) * | 2000-09-08 | 2003-10-31 | Hamilton Civic Hospitals Res | Antithrombotic compositions |
AU2001292618A1 (en) | 2000-09-12 | 2002-03-26 | Massachusetts Institute Of Technology | Methods and products related to low molecular weight heparin |
WO2002032406A2 (en) | 2000-10-18 | 2002-04-25 | Massachusetts Institute Of Technology | Methods and products related to pulmonary delivery of polysaccharides |
JP2004525110A (ja) * | 2001-02-16 | 2004-08-19 | 清水製薬株式会社 | ムコ多糖類製剤およびその製造法 |
DE60211494T2 (de) * | 2001-03-26 | 2006-10-12 | Novartis Ag | Pharmazeutische zusammensetzung enthaltend ein schlecht wasserlösliches staurosporin, eine oberflächenaktive substanz und ein wasserlösliches polymer |
BRPI0101486B1 (pt) * | 2001-04-17 | 2017-09-19 | Cristália Produtos Químicos Farmacêuticos Ltda. | Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns |
EP1385530A4 (en) * | 2001-05-09 | 2005-11-09 | Mediplex Corp | FORMULATION OF AMPHIPHILENE HEPARIN DERIVATIVES FOR IMPROVING SLIME SKIN ABSORPTION |
US7820722B2 (en) | 2001-05-11 | 2010-10-26 | Merrion Research Iii Limited | Permeation enhancers |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
US20030013680A1 (en) * | 2001-06-12 | 2003-01-16 | Keryx | Methods using glycosaminoglycans for the treatment of nephropathy |
US20030228368A1 (en) * | 2001-09-28 | 2003-12-11 | David Wynn | Edible solid composition and dosage form |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
US7429619B2 (en) | 2002-08-02 | 2008-09-30 | Mcneil Consumer Healthcare | Polyacrylic film forming compositions |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
WO2004112756A1 (en) | 2003-06-26 | 2004-12-29 | Isa Odidi | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
US20060004098A1 (en) * | 2003-07-28 | 2006-01-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compounds useful for treating neurological disorders |
US20050181047A1 (en) * | 2004-02-18 | 2005-08-18 | Jaime Romero | Compositions and methods for timed release of water-soluble nutritional supplements |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
WO2006015171A2 (en) * | 2004-07-28 | 2006-02-09 | The Texas A & M University System | Use of glycosoaminoglycans for the prevention and treatment of sepsis |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
JP2006298791A (ja) * | 2005-04-18 | 2006-11-02 | Kotobuki Seiyaku Kk | グリコサミノグリカン又はその塩を含む経口投与用医薬品、健康食品又は栄養薬品組成物。 |
US8298602B2 (en) * | 2005-10-11 | 2012-10-30 | Purecircle Sdn Bhd | Process for manufacturing a sweetener and use thereof |
CA2896083A1 (en) | 2005-12-08 | 2007-06-14 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
US9561188B2 (en) | 2006-04-03 | 2017-02-07 | Intellipharmaceutics Corporation | Controlled release delivery device comprising an organosol coat |
JP5600432B2 (ja) * | 2006-04-06 | 2014-10-01 | インスメッド, インコーポレイテッド | コアセルベート化誘導リポソーム被包法及びその調合物 |
MX2008012678A (es) | 2006-04-07 | 2008-12-17 | Merrion Res Iii Ltd | Forma de dosis oral solida que contiene un mejorador. |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
WO2009137080A1 (en) | 2008-05-07 | 2009-11-12 | Merrion Research Iii Limited | Compositions of gnrh related compounds and processes of preparation |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
EP2525783A1 (en) * | 2010-01-18 | 2012-11-28 | Cephalon France | Improved oral lysophilisates containing pvp/va |
WO2011120033A1 (en) | 2010-03-26 | 2011-09-29 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
EP2661273A4 (en) | 2011-01-07 | 2014-06-04 | Merrion Res Iii Ltd | IRON PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION |
US9357765B2 (en) | 2012-04-03 | 2016-06-07 | Smiths Medical Asd, Inc. | Heparain-bulking agent compositions and methods thereof |
JP6402097B2 (ja) | 2012-05-21 | 2018-10-10 | インスメッド インコーポレイテッド | 肺感染症を処置するためのシステム |
RU2018135921A (ru) | 2012-11-29 | 2019-02-05 | Инсмед Инкорпорейтед | Стабилизированные составы ванкомицина |
BR112016026699B1 (pt) | 2014-05-15 | 2022-09-13 | Insmed Incorporated | Uso de uma composição farmaceutica de amicacina ou de um sal farmaceuticamente aceitável desta |
US9498485B2 (en) | 2014-08-28 | 2016-11-22 | Lipocine Inc. | Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters |
WO2016033549A2 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
EP3250191B1 (en) | 2015-01-29 | 2024-01-17 | Novo Nordisk A/S | Tablets comprising glp-1 agonist and enteric coating |
JP2020503269A (ja) | 2016-11-28 | 2020-01-30 | リポカイン インコーポレーテッド | 経口ウンデカン酸テストステロン療法 |
JP7460534B2 (ja) | 2018-03-30 | 2024-04-02 | インスメッド インコーポレイテッド | リポソーム医薬品の連続製造方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3548052A (en) * | 1964-10-27 | 1970-12-15 | Canada Packers Ltd | Heparin compositions and methods of using same |
US3482014A (en) * | 1966-06-29 | 1969-12-02 | Canada Packers Ltd | Orally active heparin and method for making and using same |
US3506642A (en) * | 1967-07-03 | 1970-04-14 | Canada Packers Ltd | Stable orally active heparinoid complexes |
US3574832A (en) * | 1968-05-29 | 1971-04-13 | American Cyanamid Co | Therapeutic heparin-surfactant compositions |
US3577534A (en) * | 1968-06-20 | 1971-05-04 | Canada Packers Ltd | Stable orally active heparinoid complexes |
IT1062779B (it) * | 1974-04-04 | 1985-01-14 | Crinos Industria Farmaco | Composizione farmaceutica contenente un fattore eparinoidico |
IT1069492B (it) * | 1976-10-13 | 1985-03-25 | Alfa Farmaceutici Spa | Composizione farmaceutica sommini stratrice per via orale contenente un fattore eparinoide sospeso in un veicolo oleoso costituito da triace tato di glicerina |
GB1591306A (en) * | 1976-10-23 | 1981-06-17 | Choay Sa | Liposomes containing heparin and a process for obtaining them |
FR2492259A1 (fr) * | 1980-10-21 | 1982-04-23 | Idinvex Sa | Formulation d'heparine |
US4654327A (en) * | 1982-04-21 | 1987-03-31 | Research Corp. | Quaternary ammonium complexes of heparin |
US4510135A (en) * | 1982-04-21 | 1985-04-09 | Research Corporation | Orally administered heparin |
US4604376A (en) * | 1982-04-21 | 1986-08-05 | Research Corporation | Enteric compounds and complexes |
CH656533A5 (de) * | 1982-12-10 | 1986-07-15 | Sandoz Ag | Therapeutisches praeparat enthaltend hydrierte ergotalkaloide und niedermolekulares heparin. |
DE3331009A1 (de) * | 1983-08-27 | 1985-03-14 | Basf Ag, 6700 Ludwigshafen | Verfahren zur erhoehung der enteralen resorbierbarkeit von heparin bzw. heparinoiden sowie das so erhaeltliche heparin- bzw. heparinoidpraeparat |
JPS6054313A (ja) * | 1983-09-01 | 1985-03-28 | Terumo Corp | 腸管吸収性ヘパリン組成物 |
EP0189427B1 (en) * | 1984-05-21 | 1989-02-08 | BODOR, Nicholas S. | Orally active heparin multiplets |
US5102788A (en) * | 1988-11-21 | 1992-04-07 | Hygeia Sciences, Inc. | Immunoassay including lyophilized reactant mixture |
US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
-
1991
- 1991-01-30 IT ITBO910024A patent/IT1245761B/it active IP Right Grant
-
1992
- 1992-01-15 US US07/821,455 patent/US5252339A/en not_active Expired - Lifetime
- 1992-01-17 EP EP92100732A patent/EP0497162B1/en not_active Expired - Lifetime
- 1992-01-17 DE DE69212608T patent/DE69212608T2/de not_active Expired - Lifetime
- 1992-01-17 ES ES92100732T patent/ES2090368T3/es not_active Expired - Lifetime
- 1992-01-22 CA CA002059865A patent/CA2059865C/en not_active Expired - Lifetime
- 1992-01-29 JP JP4013943A patent/JPH0755907B2/ja not_active Expired - Lifetime
- 1992-01-30 KR KR1019920001330A patent/KR100210359B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT1245761B (it) | 1994-10-14 |
ES2090368T3 (es) | 1996-10-16 |
CA2059865A1 (en) | 1992-07-31 |
ITBO910024A0 (it) | 1991-01-30 |
DE69212608D1 (de) | 1996-09-12 |
US5252339A (en) | 1993-10-12 |
EP0497162A1 (en) | 1992-08-05 |
KR920014467A (ko) | 1992-08-25 |
DE69212608T2 (de) | 1996-11-28 |
JPH0543471A (ja) | 1993-02-23 |
CA2059865C (en) | 1999-01-26 |
JPH0755907B2 (ja) | 1995-06-14 |
EP0497162B1 (en) | 1996-08-07 |
KR100210359B1 (ko) | 1999-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ITBO910024A1 (it) | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. | |
DK0585252T3 (da) | Farmaceutiske formuleringer | |
FI921060A0 (fi) | Farmaceutiska aerosolformuleringar. | |
FI922958A0 (fi) | Farmaceutisk sammansaettning. | |
FI922252A0 (fi) | Farmaceutisk sammansaettning. | |
FI922316A0 (fi) | Farmaceutisk sammansaettning. | |
FI923581A0 (fi) | Farmaceutisk kombinationsformation. | |
DE69101931T2 (de) | Pharmazeutische Zusammensetzung. | |
ITBO910113A1 (it) | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. | |
DE4291156T1 (de) | Verbesserte pharmazeutische Zusammensetzungen | |
DE69115263T2 (de) | Pharmazeutische zusammensetzungen. | |
MX9201969A (es) | Formulacion de tableta optimizada. | |
IT1231012B (it) | Composizione farmaceutica per uso orale contenente nac. | |
DZ1559A1 (fr) | Compositions pharmaceutiques. | |
FR2698268B1 (fr) | Composition photoprotectrice administrée par voie orale. | |
MX9200146A (es) | Composiciones farmaceuticas deglutibles | |
DE69300492D1 (de) | Orale Zusammensetzung. | |
FI923371A0 (fi) | En farmaceutisk formulation. | |
FI921786A0 (fi) | Farmaceutisk foerening. | |
FI921785A0 (fi) | Farmaceutisk foerening. | |
DE69202059D1 (de) | Propensäurederivate. | |
FI920845A0 (fi) | Farmaceutiska kompositioner innehaollande interleukin-2. | |
MX9206975A (es) | Composicion farmaceutica. | |
FI916035A0 (fi) | Ny farmaceutisk komposition. | |
IT8922215A0 (it) | Formulazioni farmaceutiche. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970115 |